IAGX (Imagenetix) Research & Development: $0.00 Mil (TTM As of Jun. 2015)


What is Imagenetix Research & Development?

Imagenetix IAGX -99.00% Research & Development is $0.00 Mil as of Jun. 2015.

Research & Development is the aggregate amount of research and development expenses during the year. Imagenetix's Research & Development for the three months ended in Jun. 2015 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2015 was $0.00 Mil.

Imagenetix  (OTCPK:IAGX) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Imagenetix Research & Development Related Terms

Imagenetix Research & Development Historical Data

* Premium members only.

The historical data trend for Imagenetix's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Imagenetix Research & Development Chart

Imagenetix Annual Data
Trend Mar04 Mar05 Mar06 Mar07 Mar08 Mar09 Mar10 Mar11 Mar13 Mar15
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Imagenetix Quarterly Data
Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Dec12 Mar13 Jun13 Jun14 Sep14 Dec14 Mar15 Jun15
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Imagenetix Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2015 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
Imagenetix (IAGX) has a Research & Development of $0.00 Mil as of Jun. 2015. Research and development expense is the total cost for research and development activities. View historical data on Imagenetix and its competitors.
Is Imagenetix's Research & Development too high?
Imagenetix's current Research & Development is $0.00 Mil.
How does Imagenetix's Research & Development compare to NUVPF and ADMD?
Imagenetix's Research & Development of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Imagenetix and its competitors. Imagenetix's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Imagenetix stock overvalued right now?
Imagenetix (IAGX) has a current Research & Development of $0.00 Mil. The current Research & Development is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Imagenetix (IAGX), the current Research & Development is $0.00 Mil as of Jun. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Imagenetix Business Description

Address 10845 Rancho Bernardo Road, Suite 105, San Diego, CA, USA, 92127
Imagenetix Inc is engaged in developing, formulating licensing and selling over-the-counter, natural-based nutritional supplements. Its products include Celadrin, a product formulation for joint health; and Periodyne a periodontal product. These products are offered through multiple channels of distribution, including direct marketing companies, also known as network marketing or multi-level marketing companies and chain store retailers. Geographically all the business activities are functioned primarily through the United States.